Glucocorticoid receptor regulates organic cation transporter 1 (OCT1, SLC22A1) expression via HNF4α upregulation in primary human hepatocytes.

Journal Title: Pharmacological Reports - Year 2013, Vol 65, Issue 5

Abstract

Background: Organic cation transporter 1 (OCT1, SLC22A1) is a membrane transporter that is important for therapeutic effect of the antidiabetic drug metformin. Its liver-specific expression in hepatocytes is strongly controlled by hepatocyte nuclear factor-4α (HNF4α). HNF4α expression and transcriptional activity have been demonstrated to be augmented by glucocorticoid receptor (GR) in human hepatocytes and rodent livers. Methods: It was examined whether GR activation indirectly induces OCT1 gene expression via HNF4α up-regulation in primary human hepatocytes. We also examined which other transcription factors are involved in OCT1 gene expression and whether they are regulated by dexamethasone using qRT-PCR and gene reporter assays. Results: We found that dexamethasone significantly up-regulates OCT1 mRNA and protein in normal primary human hepatocytes, but not in hepatocyte-derived tumor cell lines HepG2 and MZ-Hep1. Consistently, we observed that HNF4α is induced by dexamethasone in primary human hepatocytes, but not in hepatocyte tumor-derived cell lines. Viral transduction of MZ-Hep1 cells with the expression constructs for HNF4α, CCAAT/enhancer binding proteins β (C/EBPβ) and peroxisome proliferator-activated receptor-γ coactivator 1α (PGC1α) demonstrated significant roles of the transcription factors in OCT1 gene regulation. We found that expression of OCT1 mRNA in human livers significantly correlates with C/EBPβ and HNF4α mRNAs expression and that C/EBPβ co-transfection stimulates OCT1 gene reporter construct in HepG2 cells. Nevertheless, neither C/EBPβ nor PGC1α were upregulated in human hepatocytes by dexamethasone. Conclusion: We can conclude that GR-induced expression of HNF4α may contribute to indirect OCT1 gene up-regulation by dexamethasone in primary human hepatocytes, but not in hepatocyte-derived tumor cell lines.

Authors and Affiliations

Alice Rulcova, Lucie Krausova, Tomas Smutny, Radim Vrzal, Zdenek Dvorak, Ramiro Jover, Petr Pavek

Keywords

Related Articles

Evaluation of the antioxidative properties of lipoxygenase inhibitors.

Background: Oxidative stress is a component of many pathological conditions including neurodegenerative diseases and inflammation. An important source of reactive oxygen species (ROS) are lipoxygenases (LOX) - enzymes re...

Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance.

Background: No previous study has assessed whether the addition of metformin potentiates fibrate action on hemostasis in prediabetic subjects. Methods: Our study included 41 fenofibrate-treated patients with impaired glu...

Inhibitory effect of albendazole and its metabolites on cytochromes P450 activities in rat and mouflon in vitro.

Cytochromes P450 (CYP) belong to the most important biotransformation enzymes, therefore, their inhibition may lead to serious pharmacological and toxicological consequences. Albendazole (ABZ) is a benzimidazole anthelmi...

Effects of GABA(B) receptor ligands in animal tests of depression and anxiety.

Preclinical evidence strongly implicates GABA(B) receptors in the pathophysiology of several psychiatric disorders including anxiety and depression. In the present study, we investigated the effects of the selective GABA...

Benzylpenicillin inhibits the renal excretion of acyclovir by OAT1 and OAT3.

Background: Acyclovir is acyclic guanosine derivative. Benzylpenicillin (PCG) is a β-lactam antibiotic. The purpose of this study was to investigate the pharmacokinetic drug-drug interaction (DDI) between PCG and acyclov...

Download PDF file
  • EP ID EP146952
  • DOI -
  • Views 87
  • Downloads 0

How To Cite

Alice Rulcova, Lucie Krausova, Tomas Smutny, Radim Vrzal, Zdenek Dvorak, Ramiro Jover, Petr Pavek (2013). Glucocorticoid receptor regulates organic cation transporter 1 (OCT1, SLC22A1) expression via HNF4α upregulation in primary human hepatocytes.. Pharmacological Reports, 65(5), 1322-1335. https://europub.co.uk/articles/-A-146952